Document is current
Any future updates will be listed below
-
Authors
Poon, Frankie
Sambathkumar, Rangarajan
Korytnikov, Roman
Aghazadeh, Yasaman https://orcid.org/0000-0003-0642-0631
Oakie, Amanda https://orcid.org/0000-0002-4749-4269
Misra, Paraish S. https://orcid.org/0000-0002-0514-8560
Sarangi, Farida https://orcid.org/0000-0003-4935-1234
Nostro, M. Cristina https://orcid.org/0000-0003-1166-8252
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (PJT-159445)
Toronto General and Western Hospital Foundation
UofT | Banting and Best Diabetes Centre, University of Toronto
Juvenile Diabetes Research Foundation Canada
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada
JDRF
- License Information
-
More Information
Article History
Received: 27 June 2022
Accepted: 27 September 2024
First Online: 9 October 2024
Competing interests
: The authors declare the following competing interests: M.C.N., F.P., R.K., and F.S. have a patent application related to the use of tankyrase inhibitors for generating insulin-producing cells (US Patent App. US17/057,130). M.C.N. and F.S. have a patent licensed to Sernova Inc. (WO2013163739A1). M.C.N. has a sponsored research agreement with Universal Cells Inc. The authors declare no other competing interests.
